The Europe Scar Treatment Market would witness market growth of 8.6% CAGR during the forecast period (2022-2028).
The therapy for scars of this kind often involves the administration of topical gels, lotions, and ointments that are readily accessible. The scar treatment works by replenishing collagen, elastin, and several other fibrous components in order to boost the skin's natural healing process and reduce the appearance of scars. The majority of these scars are caused by acne, and the usage of these treatments helps to minimize the appearance of the scars.
Since the surface of the healed lesion may now expand around the surrounding region, the scars are less noticeable. There are fillers that may be injected into scars to raise them up to the same level as the surrounding skin. These scars are sometimes referred to as ice-pick scars because of their pit-like appearance.
These are really useful, but since the filler is progressively absorbed by the body, it is possible that they may need to be repeated every few months. A device that creates microscopic channels in the skin is used in the micro-needling process. Because of this, the body is prompted to make collagen in order to mend the puncture, which ultimately results in the scar being removed.
The number of people looking to undergo cosmetic operations in Europe is showing clear signs of major growth. This is a result of the high-quality medical services that are available in the area. The use of cosmetic therapies that do not involve surgery has expanded in recent years as people have become more concerned about their overall health and look. Acne scar removal is one of the most prevalent types of cosmetic procedures performed in the United Kingdom.
The Germany market dominated the Europe Scar Treatment Market by Country in 2021; thereby, achieving a market value of $2,633.9 million by 2028. The UK market is exhibiting a CAGR of 7.7% during (2022 - 2028). Additionally, The France market would experience a CAGR of 9.5% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals, Clinics, and Retail Pharmacies/ E-commerce. Based on Product, the market is segmented into Topical Products (Creams, Gels, Silicon Sheets, and Others), Laser Products, Injectables, and Others. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Cynosure, LLC, Molnlycke Health Care AB (Investor AB), Suneva Medical, Inc., Perrigo Company PLC, Sientra, Inc., Bausch Health Companies, Inc. and Alma Lasers (Sisram Medical Ltd.)
The therapy for scars of this kind often involves the administration of topical gels, lotions, and ointments that are readily accessible. The scar treatment works by replenishing collagen, elastin, and several other fibrous components in order to boost the skin's natural healing process and reduce the appearance of scars. The majority of these scars are caused by acne, and the usage of these treatments helps to minimize the appearance of the scars.
Since the surface of the healed lesion may now expand around the surrounding region, the scars are less noticeable. There are fillers that may be injected into scars to raise them up to the same level as the surrounding skin. These scars are sometimes referred to as ice-pick scars because of their pit-like appearance.
These are really useful, but since the filler is progressively absorbed by the body, it is possible that they may need to be repeated every few months. A device that creates microscopic channels in the skin is used in the micro-needling process. Because of this, the body is prompted to make collagen in order to mend the puncture, which ultimately results in the scar being removed.
The number of people looking to undergo cosmetic operations in Europe is showing clear signs of major growth. This is a result of the high-quality medical services that are available in the area. The use of cosmetic therapies that do not involve surgery has expanded in recent years as people have become more concerned about their overall health and look. Acne scar removal is one of the most prevalent types of cosmetic procedures performed in the United Kingdom.
The Germany market dominated the Europe Scar Treatment Market by Country in 2021; thereby, achieving a market value of $2,633.9 million by 2028. The UK market is exhibiting a CAGR of 7.7% during (2022 - 2028). Additionally, The France market would experience a CAGR of 9.5% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals, Clinics, and Retail Pharmacies/ E-commerce. Based on Product, the market is segmented into Topical Products (Creams, Gels, Silicon Sheets, and Others), Laser Products, Injectables, and Others. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Lumenis Be Ltd., Merz Pharma GmbH & Co. KGaA, Cynosure, LLC, Molnlycke Health Care AB (Investor AB), Suneva Medical, Inc., Perrigo Company PLC, Sientra, Inc., Bausch Health Companies, Inc. and Alma Lasers (Sisram Medical Ltd.)
Scope of the Study
Market Segments Covered in the Report:
By End-use
- Hospitals
- Clinics
- Retail Pharmacies/ E-commerce
By Product
- Topical Products
- Creams
- Gels
- Silicon Sheets
- Others
- Laser Products
- Injectables
- Others
By Scar Type
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Smith & Nephew PLC
- Lumenis Be Ltd
- Merz Pharma GmbH & Co. KGaA
- Cynosure, LLC
- Molnlycke Health Care AB (Investor AB)
- Suneva Medical, Inc
- Perrigo Company PLC
- Sientra, Inc
- Bausch Health Companies, Inc
- Alma Lasers (Sisram Medical Ltd.)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Scar Treatment Market, by End-use
1.4.2 Europe Scar Treatment Market, by Product
1.4.3 Europe Scar Treatment Market, by Scar Type
1.4.4 Europe Scar Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Scar Treatment Market
Chapter 4. Europe Scar Treatment Market by End-use
4.1 Europe Hospitals Market by Country
4.2 Europe Clinics Market by Country
4.3 Europe Retail Pharmacies/ E-commerce Market by Country
Chapter 5. Europe Scar Treatment Market by Product
5.1 Europe Topical Products Market by Country
5.2 Europe Scar Treatment Market by Topical Products Type
5.2.1 Europe Creams Market by Country
5.2.2 Europe Gels Market by Country
5.2.3 Europe Silicon Sheets Market by Country
5.2.4 Europe Others Market by Country
5.3 Europe Laser Products Market by Country
5.4 Europe Injectables Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Scar Treatment Market by Scar Type
6.1 Europe Atrophic Scars Market by Country
6.2 Europe Hypertrophic & Keloid Scars Market by Country
6.3 Europe Contracture Scars Market by Country
6.4 Europe Stretch Marks Market by Country
Chapter 7. Europe Scar Treatment Market by Country
7.1 Germany Scar Treatment Market
7.1.1 Germany Scar Treatment Market by End-use
7.1.2 Germany Scar Treatment Market by Product
7.1.2.1 Germany Scar Treatment Market by Topical Products Type
7.1.3 Germany Scar Treatment Market by Scar Type
7.2 UK Scar Treatment Market
7.2.1 UK Scar Treatment Market by End-use
7.2.2 UK Scar Treatment Market by Product
7.2.2.1 UK Scar Treatment Market by Topical Products Type
7.2.3 UK Scar Treatment Market by Scar Type
7.3 France Scar Treatment Market
7.3.1 France Scar Treatment Market by End-use
7.3.2 France Scar Treatment Market by Product
7.3.2.1 France Scar Treatment Market by Topical Products Type
7.3.3 France Scar Treatment Market by Scar Type
7.4 Russia Scar Treatment Market
7.4.1 Russia Scar Treatment Market by End-use
7.4.2 Russia Scar Treatment Market by Product
7.4.2.1 Russia Scar Treatment Market by Topical Products Type
7.4.3 Russia Scar Treatment Market by Scar Type
7.5 Spain Scar Treatment Market
7.5.1 Spain Scar Treatment Market by End-use
7.5.2 Spain Scar Treatment Market by Product
7.5.2.1 Spain Scar Treatment Market by Topical Products Type
7.5.3 Spain Scar Treatment Market by Scar Type
7.6 Italy Scar Treatment Market
7.6.1 Italy Scar Treatment Market by End-use
7.6.2 Italy Scar Treatment Market by Product
7.6.2.1 Italy Scar Treatment Market by Topical Products Type
7.6.3 Italy Scar Treatment Market by Scar Type
7.7 Rest of Europe Scar Treatment Market
7.7.1 Rest of Europe Scar Treatment Market by End-use
7.7.2 Rest of Europe Scar Treatment Market by Product
7.7.2.1 Rest of Europe Scar Treatment Market by Topical Products Type
7.7.3 Rest of Europe Scar Treatment Market by Scar Type
Chapter 8. Company Profiles
8.1 Alma Lasers Ltd. (Sisram Medical Ltd.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Product Line and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.1.5.2 Acquisitions and Mergers:
8.2 Perrigo Company PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.3 Bausch Health Companies, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Sientra, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.5 Molnlycke Health Care AB (Investor AB)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.6 Smith & Nephew PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional and Segmental Analysis
8.6.4 Research & Development Expense
8.7 Cynosure, LLC
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.7.2.2 Product Launches and Product Expansions:
8.8 Suneva Medical, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 Lumenis Be Ltd.
8.9.1 Company Overview
8.10. Merz Pharma GmbH & Co. KGaA
8.10.1 Company Overview
Companies Mentioned
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Cynosure, LLC
- Molnlycke Health Care AB (Investor AB)
- Suneva Medical, Inc.
- Perrigo Company PLC
- Sientra, Inc.
- Bausch Health Companies, Inc.
- Alma Lasers (Sisram Medical Ltd.)
Methodology
LOADING...
